The apolipoprotein E content of HDL in cerebrospinal fluid is higher in children than in adults

Clinical Chemistry

Volumn 45, Issue 8 I, 1999, Pages 1294-1296

  Miida, Takashi ^a   Yamazaki, Fusako ^b   Sakurai, Miho ^b   Wada, Reiko ^b   Yamadera, Toru ^b   Asami, Keiko ^c   Hoshiyama, Mari ^d   Tanaka, Akira ^e   Inano, Koichi ^a   Okada, Masahiko ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NIIGATA CANCER CENTER HOSPITAL   (Japan)

^d Kashiwazaki Central Hospital   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD BRAIN BARRIER; CHILD; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN CONTENT;

EID: 0032850939     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.8.1294     Document Type: Article

References (26)

1. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wochenschr 1974;52:1158-64.
2. Lott JA, Warren P. Estimation of reference intervals for total protein in cerebrospinal fluid. Clin Chem 1989;35:1766-70.
3. Reiber H. External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem 1995;41:256-63.
4. Egleton RD, Davis TP. Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 1997;18:1431-9.
5. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D. Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 1991;196:167-76.
6. Pirttilä T, Lehtimäki T, Rinne J, Mattila K, Frey H, Nikkari T. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-4.
7. Rösler N, Wichart I, Jellinger KA. Intra vitam lumbar cerebrospinal fluid and serum postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;60:452-4.
8. Lefranc D, Vermersch P, Dallongeville J, Daems-Monpeurt C, Petit H, Delacourte A. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. Neurosci Lett 1996;212:91-4.
9. Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B, Blennow K. Apolipoprotein E in cerebrospinal fluid in 85 year-old subjects. Arch Neurol 1997;54:267-72.
10. Hahne S, Nordstedt C, Āhlin A, Nybäck H. Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls. Neurosci Lett 1997;724:90-102.
11. Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, et al. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein. Neurosci Lett 1997;229:85-8.
12. Song H, Saito K, Seishima M, Noma A, Urakami K, Nakashima K. Cerebrospinal fluid apoE and apoA-I concentration in early- and late onset Alzheimer's disease. Neurosci Lett 1997;231:175-8.
13. Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G. Cerebrospinal fluid apolipoprotein E level is increased in late onset Alzheimer's disease. J Neurol Sci 1997;145:33-9.
14. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Investig 1985;76:1501-13.
15. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917:148-61.
16. Stoll G, Meuller HW, Trapp BD, Griffin JW. Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 1989;2:170-6.
17. Roheim PS, Carey M, Forte T, Vega GL. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A 1979;76:4646-9.
18. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B and E (LDL) receptors in the brain. J Biol Chem 1987;262:14352-60.
19. Saito K, Seishima M, Heyes MP, Song H, Fujigaki S, Maeda S, et al. Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury. Biochem J 1997;321:145-9.
20. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor related protein. J Biol Chem 1996;271:30121-5.
21. Armstrong-James M, Johnson R. Quantitative studies of postnatal changes in synapses in rat superfacial motor cerebral cortex: an electron microscopical study. Z Zellorsch 1970;110:559-68.
22. Ishida BY, Frolich J, Fielding CJ. Prebeta migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioim munoassay following electrophoretic transfer. J Lipid Res 1987;28: 778-86.
23. Pedersen HE. Cerebrospinal fluid cholesterol. Quantitative analysis of unesterified and esterified cholesterol and normal values in cerebrospinal fluid. Acta Neurol Scand 1973;49:639-48.
24. Pedersen HE. Cerebrospinal fluid phospholipid. Quantitative determination of fractionated phospholipids and normal values in cerebrospinal fluid. Acta Neurol Scand 1973;49:626-38.
25. Miida I. Apolipoprotein E phenotypes in patients with coronary artery disease. Tohoku J Exp Med 1990;160:177-87.
26. Schumann GB, Schweitzer SC. Cerebrospinal fluid and other body fluids. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods, 18th ed. New York: WB Saunders, 1991:445-73.